BW Businessworld
COVID-19 Could Give Momentum To Indian Healthcare Industry: HUL CMD
Making a case for restarting manufacturing of APIs Active Pharmaceutical Ingredients), Mehta said this would not only help India become the “affordable healthcare capital of the world” but would also be a massive growth engine for the country
Photo Credit :
The COVID-19 pandemic could provide India an opportunity to scale up the healthcare industry and be a major supplier of pharmaceutical products to the world, Hindustan Unilever Chairman & Managing Director Sanjiv Mehta said on Saturday.
Making a case for restarting manufacturing of APIs Active Pharmaceutical Ingredients), Mehta said this would not only help India become the “affordable healthcare capital of the world” but would also be a massive growth engine for the country.